Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as ixabepilone and estramustine, use different
ways to stop tumor cells from dividing so they stop growing or die. It is not yet known
whether BMS-247550 is more effective with or without estramustine in treating prostate
cancer.
PURPOSE: This randomized phase I/II trial is studying the best dose of ixabepilone when given
together with estramustine and to see how well giving ixabepilone together with estramustine
works compared to ixabepilone alone in treating patients with progressive prostate cancer.